Eulogy for the Metabolic Clinical Investigator? - Wikidata - wikimedia - TriplyDB

Eulogy for the Metabolic Clinical Investigator?

Eulogy for the Metabolic Clinical Investigator?

http://www.wikidata.org/entity/Q42392159

about

Human brown adipose tissue as a target for obesity management; beyond cold-induced thermogenesis.No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia.

P2860

Q39434608-BFA40609-F37C-4173-86C7-3A6DC5B581A5 Q47785459-088EA7AF-4003-4282-A314-9026AD875902

P2860

Eulogy for the Metabolic Clinical Investigator?

http://www.wikidata.org/entity/Q42392159

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Eulogy for the Metabolic Clinical Investigator?

@en

Eulogy for the Metabolic Clinical Investigator?

@nl

type

label

Eulogy for the Metabolic Clinical Investigator?

@en

Eulogy for the Metabolic Clinical Investigator?

@nl

prefLabel

Eulogy for the Metabolic Clinical Investigator?

@en

Eulogy for the Metabolic Clinical Investigator?

@nl

P1433

Q42392159-30A21B78-D671-48B3-B345-B8118A6354EC

P1476

Q42392159-35B22FE7-0143-4DAA-B4A8-25E63F3E6AC2

P2093

Q42392159-255FD5B8-404C-48DB-90A1-65D22A3D6F60

Q42392159-431168AE-EE79-48E2-A04B-FD1CF3BF4DA7

Q42392159-FC551083-EA73-490A-A464-9416946C4327

P2860

Q42392159-028FE404-A554-4073-A7BD-E3733FB1273B

Q42392159-09C0DD7D-B6F4-4C10-B101-6256A4FA361A

Q42392159-2115A1F7-5C72-46D3-A876-D9EA9F7F8409

Q42392159-227281A3-6585-47EA-B00C-FD29A19470AA

Q42392159-3654FE78-98F5-4211-A85B-236A878AE6A1

Q42392159-5EF19B1B-796C-4A76-B56A-78DF8F68336A

Q42392159-6641DBE8-CDE4-4E81-9C4A-12DCAC00B452

Q42392159-7A30163B-5319-413F-865E-832B864529B8

Q42392159-834BAB4E-CC82-496E-BE9E-62AD89FA67C1

Q42392159-8C9D7220-2665-46A0-88CE-43E8F29D2BC0

P304

Q42392159-C3C9A05F-CEC8-446A-85F7-B624E3019305

P31

Q42392159-85173F1A-BE00-421F-8E81-2E223A3F5A3C

Q42392159-bc7b1b9e-c19e-498b-bafb-5b296ece23ff

P356

Q42392159-BE1CB21A-4215-47B9-B755-CD8615C0A235

P407

Q42392159-547B6B4D-F051-41E2-AA2F-6512852E2D05

P433

Q42392159-E5DDA553-90A8-452C-83F1-75058D25E013

P478

Q42392159-6653AE23-C946-4CF8-8A29-58ED1F917FC0

P577

Q42392159-066A1683-83E9-488D-8A2D-F69BE2FEE362

P698

Q42392159-978B73C6-13FD-4B31-943D-45369D36E405

P932

Q42392159-7D5DA259-A7D2-4757-BE00-56BA0385DB5E

P356

P1433

P1476

Eulogy for the Metabolic Clinical Investigator?

@en

P2093

Adrian Vella

http://www.w3.org/2001/XMLSchema#string

K Sreekumaran Nair

http://www.w3.org/2001/XMLSchema#string

Michael D Jensen

http://www.w3.org/2001/XMLSchema#string

P2860

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Cellular mechanisms of insulin resistance in humans.

The glucagon-like peptides.

Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults.

Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types.

Splanchnic lipolysis in human obesity.

The case of visceral fat: argument for the defense.

Incretin hormones--an update.

Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?

P304

2821-2823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB16-0923

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27659223

http://www.w3.org/2001/XMLSchema#string

P932

5033260

http://www.w3.org/2001/XMLSchema#string